Company Filing History:
Years Active: 2011
Title: Terhi Karpanen: Innovator in Angiogenic Research
Introduction
Terhi Karpanen is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of angiogenic research, particularly through her innovative work on modified VEGF-A. Her research focuses on enhancing the properties of vascular endothelial growth factor, which plays a crucial role in blood vessel formation.
Latest Patents
Karpanen holds a patent for a modified version of VEGF-A with improved angiogenic properties. The patent describes methods and compositions for creating chimeric polypeptides that include a VEGFR-2 ligand. These chimeric molecules maintain VEGFR-2 binding activity while exhibiting enhanced angiogenic activity compared to native VEGF-A. This advancement has the potential to impact therapeutic approaches in various medical fields.
Career Highlights
Throughout her career, Terhi Karpanen has been associated with Vegenics Pty Limited, where she has furthered her research and development efforts. Her work has garnered attention for its innovative approach to addressing challenges in angiogenesis and related medical applications.
Collaborations
Karpanen has collaborated with notable researchers in her field, including Kari Alitalo and Tuomas Tammela. These partnerships have contributed to the advancement of knowledge and technology in angiogenic research.
Conclusion
Terhi Karpanen's contributions to the field of angiogenic research through her innovative patent and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical therapies related to blood vessel formation.